While expected, Intercept's approval delay adds to NASH uncertainty

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jan 18, 2020 at 7:52 PM.

  1. #1 cafead, Jan 18, 2020 at 7:52 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via In a Friday disclosure, Intercept Pharmaceuticals said it could take up to three months longer for regulators to make an approval decision on the company's closely watched liver disease drug. The approval deadline is now set for June 26 rather than March 26.

    article source
     
    Quote

Reply to Thread